Gastroenterology: A global study of trends in pancreatic cancer morbidity and mortality.

Recently, researchers assessed global and regional burdens, risk factors and epidemiological trends in pancreatic cancer between gender and age groups.
researchers used data from the GLOBOCAN database to estimate pancreatic cancer morbidity and mortality in 184 countries.
the relationship between lifestyle and metabolic risk factors, and the incidence and mortality of pancreatic cancer were examined by linear regression analysis of single and multivariates.
the age-standardized (ASRs) morbidity and mortality rates for specific countries up to 2017 from cancer registries in 48 countries.
2018, pancreatic cancer morbidity and mortality rates were highest in countries with very high (ASRs, 7.7 and 4.9) and high (ASRs, 6.9 and 4.6) human development index (HDIs, which reflect the degree of development).
high rates of smoking, alcohol consumption, exercise deficiency, obesity, high blood pressure and high cholesterol in countries with higher morbidity and mortality rates.
statistics, the incidence of pancreatic cancer has increased in 14 countries (average annual percentage change (AAPCs) to 8.85 to 0.41) and 17 countries (AAPCs, 6.04 to 0.87).
in terms of mortality, there was an increase in mortality rates among men in 8 countries (AAPCs, 4.20 to 0.55) and among women in 14 countries (AAPCs, 5.83 to 0.78).
in 18 countries (AAPCs, 7.83-0.91), the incidence of pancreatic cancer increased in people aged 50 or over, but in 8 countries (AAPCs, 8. The incidence of pancreatic cancer is also on the rise in 75-2.82) and 4 countries (AAPCs, 11.07-8.31).
analysis of data from 184 countries, the study found an increase in the incidence and mortality of pancreatic cancer worldwide, especially among women and people over the age of 50.
.